Syndax Pharmaceuticals, Inc. (SNDX)
8.575
-0.62
(-6.79%)
USD |
NASDAQ |
Nov 18, 16:00
8.57
0.00 (0.00%)
After-Hours: 19:44
Syndax Pharmaceuticals Total Return Level : 9.20 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 9.20 |
| November 16, 2026 | 9.13 |
| November 13, 2026 | 9.45 |
| November 12, 2026 | 9.54 |
| November 11, 2026 | 9.59 |
| November 10, 2026 | 9.49 |
| November 09, 2026 | 9.55 |
| November 06, 2026 | 9.54 |
| November 05, 2026 | 9.37 |
| November 04, 2026 | 10.45 |
| November 03, 2026 | 14.29 |
| November 02, 2026 | 13.10 |
| October 30, 2026 | 13.65 |
| October 29, 2026 | 14.15 |
| October 28, 2026 | 14.32 |
| October 27, 2026 | 13.69 |
| October 26, 2026 | 13.22 |
| October 23, 2026 | 13.40 |
| October 22, 2026 | 13.57 |
| October 21, 2026 | 13.15 |
| October 20, 2026 | 13.25 |
| October 19, 2026 | 13.09 |
| October 16, 2026 | 12.90 |
| October 15, 2026 | 13.65 |
| October 14, 2026 | 13.53 |
| Date | Value |
|---|---|
| October 13, 2026 | 13.95 |
| October 12, 2026 | 16.55 |
| October 09, 2026 | 16.99 |
| October 08, 2026 | 16.90 |
| October 07, 2026 | 17.03 |
| October 06, 2026 | 17.37 |
| October 05, 2026 | 17.83 |
| October 02, 2026 | 17.60 |
| October 01, 2026 | 18.22 |
| September 30, 2026 | 18.80 |
| September 29, 2026 | 18.24 |
| September 28, 2026 | 17.86 |
| September 25, 2026 | 18.20 |
| September 24, 2026 | 17.97 |
| September 23, 2026 | 17.64 |
| September 22, 2026 | 18.18 |
| September 21, 2026 | 18.07 |
| September 18, 2026 | 17.62 |
| September 17, 2026 | 17.68 |
| September 16, 2026 | 17.28 |
| September 15, 2026 | 18.09 |
| September 14, 2026 | 18.35 |
| September 11, 2026 | 18.18 |
| September 10, 2026 | 18.82 |
| September 09, 2026 | 19.84 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.32 |
| Emergent BioSolutions, Inc. | 5.61 |
| Incyte Corp. | 119.09 |
| Vertex Pharmaceuticals, Inc. | 534.20 |
| Travere Therapeutics, Inc. | 51.10 |